Holen Sie sich die Stockscreener-App
0.2429
2.88%
-0.0072
Schlusskurs vom Vortag:
$0.2501
Offen:
$0.251
24-Stunden-Volumen:
606.40K
Relative Volume:
0.07
Marktkapitalisierung:
$4.74M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-0.0746
EPS:
-3.2558
Netto-Cashflow:
-
1W Leistung:
-24.82%
1M Leistung:
-13.96%
6M Leistung:
-68.37%
1J Leistung:
-80.87%
1-Tages-Spanne:
$0.2306
$0.2664
1-Wochen-Bereich:
$0.2306
$0.325
52-Wochen-Spanne:
$0.177
$1.60
Bionomics Ltd Adr Stock (BNOX) Company Profile
Firmenname
Bionomics Ltd Adr
Sektor
Branche
Telefon
61 8 8150 7400
Adresse
200 GREENHILL ROAD, EASTWOOD SA
Vergleichen Sie BNOX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BNOX
Bionomics Ltd Adr
|
0.2429 | 4.74M | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
397.27 | 102.31B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
701.85 | 77.13B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
623.82 | 37.30B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
245.44 | 31.66B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
113.08 | 27.11B | 3.30B | -501.07M | 1.03B | -2.1146 |
Bionomics Ltd Adr Stock (BNOX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Bionomics Ltd Adr Aktie (BNOX) Neueste Nachrichten
What Do Analysts Think About Bionomics Ltd. ADR’s (NASDAQ:BNOX) Future? - Stocks Register
Bionomics Reminds Shareholders to Cast their Vote for Re-Domiciliation from Australia to the United States - GlobeNewswire Inc.
United States shares higher at close of trade; Dow Jones Industrial Average up 3.56% - MSN
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.88% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 3.55% - MSN
U.S. shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Bionomics announces shareholder meeting for US re-domiciliation - Investing.com India
Bionomics Provides an Update on Re-domiciliation via Scheme of Arrangement - GlobeNewswire
U.S. stocks higher at close of trade; Dow Jones Industrial Average up 3.58% - MSN
United States shares higher at close of trade; Dow Jones Industrial Average up 0.89% - MSN
Why Bionomics (BNOX) Stock Is Up 100% Today - Benzinga
Why Palantir Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket - Benzinga
Bionomics secures AUS$1M milestone payment from Carina Biotech - Investing.com India
Bionomics secures AUS$1M milestone payment from Carina Biotech By Investing.com - Investing.com UK
Here’s Why DENTSPLY Sirona Inc (NASDAQ: XRAY) Is An Attractive Investment Right Now - Stocks Register
BNOX stock touches 52-week low at $0.23 amid sharp decline By Investing.com - Investing.com South Africa
BNOX stock touches 52-week low at $0.23 amid sharp decline - Investing.com India
Tonix Pharmaceuticals Holding Corp (TNXP): An Important Analyst Insights - Stocks Register
Sprinklr Inc (NYSE: CXM) Up 1.53%: This Is What Analysts Are Now Forecasting - Stocks Register
AgEagle Aerial Systems Inc. (AMEX: UAVS): Blank Check On Growth? - Stocks Register
BNOX stock touches 52-week low at $0.23 amid sharp annual decline - Investing.com Australia
Bionomics announces director resignation - Investing.com India
Bionomics announces director resignation By Investing.com - Investing.com UK
Analyzing Ratios: Bionomics Ltd. ADR (BNOX)’s Financial Story Unveiled - The Dwinnex
Apeiron entities sell Bionomics shares worth $82,526 - Investing.com
Apeiron entities sell Bionomics shares worth $82,526 By Investing.com - Investing.com South Africa
Bionomics commences phase 3 trial in anxiety disorder - Investing.com
BNOX stock touches 52-week low at $0.39 amid sharp annual decline - Investing.com
Bionomics plans U.S. re-domiciliation for strategic growth - Investing.com India
Bionomics plans U.S. re-domiciliation for strategic growth By Investing.com - Investing.com South Africa
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: A Technical Analysis Perspective - The InvestChronicle
Market Watch: Bionomics Ltd. ADR (BNOX)’s Noteworthy Drop, Closing at 0.64 - The Dwinnex
Bionomics Ltd. ADR (BNOX) stock analysis: A simple moving average approach - US Post News
Ratio Analysis: Unpacking Bionomics Ltd. ADR (BNOX)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex
Is it possible to buy Bionomics Ltd. ADR(BNOX) shares at a good price now? - US Post News
Investor’s Toolkit: Key Ratios for Assessing Bionomics Ltd. ADR (BNOX)’s Performance - The Dwinnex
Recursion Pharmaceuticals Inc (RXRX) Has Recovered 32.29% From Its Low: Is This The Beginning Of A Trend? - Stocks Register
An analyst sees good growth prospects for Bionomics Ltd. ADR (BNOX) - SETE News
Bionomics Ltd. ADR [BNOX] Stock trading around $0.83 per share: What’s Next? - The DBT News
Bionomics Ltd. ADR: A Year of Highs, Lows, and Market Resilience - The InvestChronicle
Bionomics to Provide a Corporate Update and Discuss - GlobeNewswire
Bionomics Ltd. ADR (BNOX) Stock: A Year of Decreases and Increases - The InvestChronicle
Nauticus Robotics Inc [KITT] Stock trading around $0.13 per share: What’s Next? - The DBT News
Chuy’s Holdings Inc [CHUY] fell -2.33% so far this year. What now? - The DBT News
Market cap of Kintara Therapeutics Inc [KTRA] reaches 15.16M – now what? - The DBT News
Bionomics Ltd. ADR Inc. (BNOX) Price Performance: The Role of Share Buybacks and Stock Splits - The InvestChronicle
Bionomics commences phase 3 trial for social anxiety treatment - Investing.com
Bionomics faces Nasdaq delisting over share price - Investing.com
Stock Market Recap: Bionomics Ltd. ADR (BNOX) Concludes at 0.69, a -2.76 Surge/Decline – DWinneX - The Dwinnex
Finanzdaten der Bionomics Ltd Adr-Aktie (BNOX)
Es liegen keine Finanzdaten für Bionomics Ltd Adr (BNOX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):